I am a
Home I AM A Search Login

Papers of the Week


Papers: 8 Jun 2024 - 14 Jun 2024


2024 Jun 05


CNS Neurol Disord Drug Targets


38847252

Safety and Efficacy of Calcitonin Gene-related Peptide Receptor Antagonists and Selective Serotonin Receptor Agonist in the Management of Migraine: A Systematic Review and Meta-analysis.

Authors

Singh P, Ponnada RK, Sharma R, Sumadhura B, Kumar A, Datusalia AK

Abstract

Recently, US Food and Drug Administration (FDA) has approved calcitonin gene-related peptide receptor antagonists (rimegepant, and ubrogepant), and selective serotonin receptor agonists (lasmiditan) in the management of migraine. However, the exact safety and efficacy profile of these drugs is unclear so far.